MUC16 and neoplasm: In order to associate the immune cell profiles with clinicopathological OC patient characteristics, like FIGO stage, serum CA125 level at surgery, or residual tumor after surgery, the previous main cohort of 24 patients was expanded by four additional OC patients, where only PB samples were received for immune cell monitoring.